ResMed Inc (RMD)
193.00
-1.74
(-0.89%)
USD |
NYSE |
Jul 08, 16:00
193.00
0.00 (0.00%)
After-Hours: 18:35
ResMed SG&A Expense (TTM): 915.63M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 915.63M |
December 31, 2023 | 914.17M |
September 30, 2023 | 903.69M |
June 30, 2023 | 874.75M |
March 31, 2023 | 827.09M |
December 31, 2022 | 781.03M |
September 30, 2022 | 754.72M |
June 30, 2022 | 737.51M |
March 31, 2022 | 725.96M |
December 31, 2021 | 704.01M |
September 30, 2021 | 688.12M |
June 30, 2021 | 670.39M |
March 31, 2021 | 654.29M |
December 31, 2020 | 666.28M |
September 30, 2020 | 668.24M |
June 30, 2020 | 676.69M |
March 31, 2020 | 682.90M |
December 31, 2019 | 674.99M |
September 30, 2019 | 665.15M |
June 30, 2019 | 645.01M |
March 31, 2019 | 630.22M |
December 31, 2018 | 613.58M |
September 30, 2018 | 603.82M |
June 30, 2018 | 600.37M |
March 31, 2018 | 591.50M |
Date | Value |
---|---|
December 31, 2017 | 581.47M |
September 30, 2017 | 568.96M |
June 30, 2017 | 553.96M |
March 31, 2017 | 541.86M |
December 31, 2016 | 526.90M |
September 30, 2016 | 505.81M |
June 30, 2016 | 488.06M |
March 31, 2016 | 481.46M |
December 31, 2015 | 474.90M |
September 30, 2015 | 479.20M |
June 30, 2015 | 478.63M |
March 31, 2015 | 471.62M |
December 31, 2014 | 470.38M |
September 30, 2014 | 459.61M |
June 30, 2014 | 450.41M |
March 31, 2014 | 443.23M |
December 31, 2013 | 437.76M |
September 30, 2013 | 433.82M |
June 30, 2013 | 430.80M |
March 31, 2013 | 421.66M |
December 31, 2012 | 413.98M |
September 30, 2012 | 406.72M |
June 30, 2012 | 402.62M |
March 31, 2012 | 400.04M |
December 31, 2011 | 390.63M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
654.29M
Minimum
Mar 2021
915.63M
Maximum
Mar 2024
746.61M
Average
704.01M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
Boston Scientific Corp | 5.339B |
Align Technology Inc | 1.716B |
Haemonetics Corp | 431.78M |
Inspire Medical Systems Inc | 475.59M |
Abbott Laboratories | 11.15B |